Clinical manifestations of human coronavirus NL63 infection in children in Taiwan.

PubWeight™: 1.03‹?› | Rank: Top 15%

🔗 View Article (PMID 17297612)

Published in Eur J Pediatr on February 13, 2007

Authors

Ping-Sheng Wu1, Luan-Yin Chang, B Berkhout, L van der Hoek, Chun-Yi Lu, Chuan-Liang Kao, Ping-Ing Lee, Pei-Lan Shao, Chin-Yun Lee, Fu-Yuan Huang, Li-Min Huang

Author Affiliations

1: Department of Pediatrics, Buddhist Tzu Chi General Hospital, Taipei Branch, Taipei, Taiwan.

Articles citing this

Human coronavirus in young children hospitalized for acute respiratory illness and asymptomatic controls. Pediatr Infect Dis J (2012) 1.93

Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method. J Clin Microbiol (2010) 1.54

Systematic assembly of a full-length infectious clone of human coronavirus NL63. J Virol (2008) 1.23

Structure of the main protease from a global infectious human coronavirus, HCoV-HKU1. J Virol (2008) 1.18

The role of infections and coinfections with newly identified and emerging respiratory viruses in children. Virol J (2012) 1.17

Coronavirus infection and hospitalizations for acute respiratory illness in young children. J Med Virol (2009) 1.08

From SARS coronavirus to novel animal and human coronaviruses. J Thorac Dis (2013) 0.96

Understanding Human Coronavirus HCoV-NL63. Open Virol J (2010) 0.91

Effects of coronavirus infections in children. Emerg Infect Dis (2010) 0.90

Interaction of severe acute respiratory syndrome-coronavirus and NL63 coronavirus spike proteins with angiotensin converting enzyme-2. J Gen Virol (2008) 0.83

Infection with human coronavirus NL63 enhances streptococcal adherence to epithelial cells. J Gen Virol (2011) 0.80

New Epidemiological and Clinical Signatures of 18 Pathogens from Respiratory Tract Infections Based on a 5-Year Study. PLoS One (2015) 0.80

The nucleocapsid protein of human coronavirus NL63. PLoS One (2015) 0.76

The Role of Human Coronaviruses in Children Hospitalized for Acute Bronchiolitis, Acute Gastroenteritis, and Febrile Seizures: A 2-Year Prospective Study. PLoS One (2016) 0.75

Articles cited by this

Identification of a new human coronavirus. Nat Med (2004) 11.24

Association between a novel human coronavirus and Kawasaki disease. J Infect Dis (2005) 3.71

Evidence of a novel human coronavirus that is associated with respiratory tract disease in infants and young children. J Infect Dis (2005) 2.60

A novel pancoronavirus RT-PCR assay: frequent detection of human coronavirus NL63 in children hospitalized with respiratory tract infections in Belgium. BMC Infect Dis (2005) 2.28

New human coronavirus, HCoV-NL63, associated with severe lower respiratory tract disease in Australia. J Med Virol (2005) 2.04

Croup is associated with the novel coronavirus NL63. PLoS Med (2005) 2.03

Human coronavirus NL63 infection and other coronavirus infections in children hospitalized with acute respiratory disease in Hong Kong, China. Clin Infect Dis (2005) 2.03

Human coronavirus NL63 infection in Canada. J Infect Dis (2005) 1.93

Croup: an 11-year study in a pediatric practice. Pediatrics (1983) 1.90

Pediatric hospitalizations for croup (laryngotracheobronchitis): biennial increases associated with human parainfluenza virus 1 epidemics. J Infect Dis (1997) 1.69

Human coronavirus NL63, France. Emerg Infect Dis (2005) 1.33

Detection of human coronavirus-NL63 in children in Japan. Pediatr Infect Dis J (2005) 1.01

Lack of association between New Haven coronavirus and Kawasaki disease. J Infect Dis (2005) 1.01

Human coronavirus NL63 is not detected in the respiratory tracts of children with acute Kawasaki disease. J Infect Dis (2005) 0.97

Articles by these authors

Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR. Science (1991) 4.66

Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme. EMBO J (1996) 3.92

Syncytium-inducing (SI) phenotype suppression at seroconversion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population. J Virol (1995) 2.74

Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination. Hepatology (2004) 2.74

Pyogenic liver abscess as endemic disease, Taiwan. Emerg Infect Dis (2008) 2.70

Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G. J Virol (2000) 2.65

Neurodevelopment and cognition in children after enterovirus 71 infection. N Engl J Med (2007) 2.56

Reduced replication of human immunodeficiency virus type 1 mutants that use reverse transcription primers other than the natural tRNA(3Lys). J Virol (1995) 2.47

Two alternating structures of the HIV-1 leader RNA. RNA (2001) 2.47

Human parechovirus infections in Dutch children and the association between serotype and disease severity. Clin Infect Dis (2005) 2.41

Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II. J Virol (2008) 2.39

Novel swine-origin influenza virus A (H1N1): the first pandemic of the 21st century. J Formos Med Assoc (2009) 2.28

Enterovirus 71 outbreaks, Taiwan: occurrence and recognition. Emerg Infect Dis (2003) 2.26

Screening young children with a first febrile urinary tract infection for high-grade vesicoureteral reflux with renal ultrasound scanning and technetium-99m-labeled dimercaptosuccinic acid scanning. J Pediatr (2009) 2.15

Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. Gastroenterology (2011) 2.07

Proinflammatory cytokine reactions in enterovirus 71 infections of the central nervous system. Clin Infect Dis (2003) 2.00

An outbreak of coxsackievirus A6 hand, foot, and mouth disease associated with onychomadesis in Taiwan, 2010. BMC Infect Dis (2011) 1.96

A hairpin structure in the R region of the human immunodeficiency virus type 1 RNA genome is instrumental in polyadenylation site selection. J Virol (1999) 1.91

A conserved hairpin motif in the R-U5 region of the human immunodeficiency virus type 1 RNA genome is essential for replication. J Virol (1997) 1.91

Initial appearance of the 184Ile variant in lamivudine-treated patients is caused by the mutational bias of human immunodeficiency virus type 1 reverse transcriptase. J Virol (1997) 1.91

The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin Infect Dis (2002) 1.90

Strict control of human immunodeficiency virus type 1 replication by a genetic switch: Tet for Tat. J Virol (2001) 1.89

Enterovirus-induced miR-141 contributes to shutoff of host protein translation by targeting the translation initiation factor eIF4E. Cell Host Microbe (2011) 1.88

Immunodominance and antigenic variation of the principal neutralization domain of HIV-1. Virology (1991) 1.85

Epidemiologic features of Kawasaki disease in Taiwan, 2003-2006. Pediatrics (2009) 1.85

An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells. J Virol (2004) 1.81

Prevalence of Campylobacter-associated diarrhea among patients infected with human immunodeficiency virus. Clin Infect Dis (1997) 1.80

High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: implications for pathogenesis. Virology (2003) 1.79

Determination of immune memory to hepatitis B vaccination through early booster response in college students. Hepatology (2010) 1.78

High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan. Antimicrob Agents Chemother (2003) 1.75

Evolution of a disrupted TAR RNA hairpin structure in the HIV-1 virus. EMBO J (1994) 1.74

Initiation of HIV-1 reverse transcription is regulated by a primer activation signal. J Biol Chem (2001) 1.71

Detection of dengue virus replication in peripheral blood mononuclear cells from dengue virus type 2-infected patients by a reverse transcription-real-time PCR assay. J Clin Microbiol (2002) 1.71

Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a phase III randomized controlled trial in children. J Infect Dis (2013) 1.70

Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies. Gastroenterology (2007) 1.70

Assembly of the human T cell receptor-CD3 complex takes place in the endoplasmic reticulum and involves intermediary complexes between the CD3-gamma.delta.epsilon core and single T cell receptor alpha or beta chains. J Biol Chem (1988) 1.68

Human antibody response to a strain-specific HIV-1 gp120 epitope associated with cell fusion inhibition. AIDS (1988) 1.68

Characterization of severe acute respiratory syndrome coronavirus genomes in Taiwan: molecular epidemiology and genome evolution. Proc Natl Acad Sci U S A (2004) 1.66

Epidemiology and impacts of children hospitalized with pneumonia from 1997 to 2004 in Taiwan. Pediatr Pulmonol (2009) 1.62

Variable expression of class 1 outer membrane protein in Neisseria meningitidis is caused by variation in the spacing between the -10 and -35 regions of the promoter. J Bacteriol (1995) 1.61

Nucleotide substitution patterns can predict the requirements for drug-resistance of HIV-1 proteins. Antiviral Res (1996) 1.59

Evolution of EV71 genogroup in Taiwan from 1998 to 2005: an emerging of subgenogroup C4 of EV71. J Med Virol (2006) 1.58

Incidence and case-fatality rates resulting from the 1998 enterovirus 71 outbreak in Taiwan. J Med Virol (2002) 1.57

Bacteremia caused by antimicrobial resistant Campylobacter species at a medical center in Taiwan, 1998-2008. J Infect (2012) 1.57

A comparison of safety, tolerability and immunogenicity of Oka/Merck varicella vaccine and VARILRIX in healthy children. Vaccine (2002) 1.56

Clinical responses of patients with Kawasaki disease to different brands of intravenous immunoglobulin. J Pediatr (2006) 1.56

Microbiologic characteristics, serologic responses, and clinical manifestations in severe acute respiratory syndrome, Taiwan. Emerg Infect Dis (2003) 1.55

Fatal coxsackievirus A16 infection. Pediatr Infect Dis J (2004) 1.55

Direct evidence for translational regulation by leader RNA and Tat protein of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1990) 1.52

Is avian influenza A (H7N9) virus staggering its way to humans? J Formos Med Assoc (2013) 1.52

Establishment of a young mouse model and identification of an allelic variation of zmpB in complicated pneumonia caused by Streptococcus pneumoniae. Crit Care Med (2008) 1.50

Status of cellular rather than humoral immunity is correlated with clinical outcome of enterovirus 71. Pediatr Res (2006) 1.50

Slower decline of plasma HIV-1 RNA following highly suppressive antiretroviral therapy in primary compared with chronic infection. AIDS (2000) 1.47

Vibrio cholerae O1 infection in Taiwan. J Infect (2010) 1.45

Acinetobacter baumannii and Acinetobacter genospecies 13TU and 3 bacteraemia: comparison of clinical features, prognostic factors and outcomes. J Antimicrob Chemother (2011) 1.44

SARS in hospital emergency room. Emerg Infect Dis (2004) 1.44

Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization. J Infect Dis (2008) 1.43

Immunogenicity and protection of a recombinant human adenovirus serotype 35-based malaria vaccine against Plasmodium yoelii in mice. Infect Immun (2006) 1.43

Carrier rate of zidovudine-resistant HIV-1: the impact of failing therapy on transmission of resistant strains. AIDS (2001) 1.42

Optimization of the Tet-On system for regulated gene expression through viral evolution. Gene Ther (2006) 1.42

Influenza pandemics: past, present and future. J Formos Med Assoc (2006) 1.41

Clinical characteristics and survival of trisomy 18 in a medical center in Taipei, 1988-2004. Am J Med Genet A (2006) 1.41

Clinical features of type 1 diabetic children at initial diagnosis. Acta Paediatr Taiwan (2004) 1.41

Comparison of 5' and 3' long terminal repeat promoter function in human immunodeficiency virus. J Virol (1994) 1.41

Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2(-/-)gammac(-/-)) mouse model. Gene Ther (2008) 1.40

In vitro evolution of a highly replicating, doxycycline-dependent HIV for applications in vaccine studies. Proc Natl Acad Sci U S A (2001) 1.40

Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia. Pediatr Infect Dis J (2007) 1.39

Determination of the minimal amount of Tat activity required for human immunodeficiency virus type 1 replication. Virology (1997) 1.39

Current challenges in the management of invasive fungal infections. J Infect Chemother (2008) 1.38

Requirements for cell surface expression of the human TCR/CD3 complex in non-T cells. Int Immunol (1991) 1.36

The ability of the HIV-1 AAUAAA signal to bind polyadenylation factors is controlled by local RNA structure. Nucleic Acids Res (1999) 1.36

Human TLR3 recognizes dengue virus and modulates viral replication in vitro. Cell Microbiol (2009) 1.35

Rapid creation of a temporary isolation ward for patients with severe acute respiratory syndrome in Taiwan. Infect Control Hosp Epidemiol (2004) 1.32

Regulation of HIV expression: mechanisms of action of Tat and Rev. AIDS (1991) 1.31